Osteopore Ltd. ( (AU:OSX) ) has issued an update.
Osteopore Limited has continued to draw on its previously arranged funding facility, confirming that subscribers have taken up an additional sub-tranche of Tranche 2 redeemable convertible notes worth A$250,000. This latest drawdown lifts the company’s total utilisation under the multi-tranche, A$20 million note program and underscores its ongoing access to structured financing.
The proceeds from the newly issued notes will be directed toward Osteopore’s ordinary course of business and potential future developments, projects and investments as opportunities arise. The incremental capital is expected to support the company’s operational needs and growth initiatives, reinforcing its funding base as it advances its regenerative implant technologies in global markets.
More about Osteopore Ltd.
Osteopore Limited is an Australian-Singaporean regenerative medicine company that is a global leader in 3D-printed biomimetic and bioresorbable implants. The company develops patented scaffold products using naturally dissolving polymers to stimulate natural bone healing and reduce complications associated with permanent bone implants across multiple clinical segments.
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$2.71M
See more data about OSX stock on TipRanks’ Stock Analysis page.